Heather R Kregel1,2,3, Gabrielle E Hatton1,2,3, Kayla D Isbell1,2,3, Hanne H Henriksen4, Jakob Stensballe4,5, Per I Johansson4, Lillian S Kao1,2,3, Charles E Wade1,3. 1. Division of Acute Care Surgery, Department of Surgery, McGovern Medical School at UTHealth, Houston, Texas. 2. Center for Surgical Trials and Evidence-Based Practice, McGovern Medical School at UTHealth, Houston, Texas. 3. Center for Translational Injury Research, Houston, Texas. 4. Section for Transfusion Medicine, Capital Region Blood Bank, University of Copenhagen, Copenhagen, Denmark. 5. Department of Anaesthesia and Trauma Centre, Centre of Head and Orthopedics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: Shock-induced endothelial dysfunction, evidenced by elevated soluble thrombomodulin (sTM) and syndecan-1 (Syn-1), is associated with poor outcomes after trauma. The association of endothelial dysfunction and overt shock has been demonstrated; it is unknown if hypoperfusion in the setting of normal vital signs (occult hypoperfusion [OH]) is associated with endothelial dysfunction. We hypothesized that sTM and Syn-1 would be elevated in patients with OH when compared to patients with normal perfusion. METHODS: A single-center study of patients requiring highest-level trauma activation (2012-2016) was performed. Trauma bay arrival plasma Syn-1 and sTM were measured by enzyme-linked immunosorbent assay. Shock was defined as systolic blood pressure (SBP) <90 mm Hg or heart rate (HR) ≥120 bpm. OH was defined as SBP ≥ 90, HR < 120, and base excess (BE) ≤-3. Normal perfusion was assigned to all others. Univariate and multivariable analyses were performed. RESULTS: Of 520 patients, 35% presented with OH and 26% with shock. Demographics were similar between groups. Patients with normal perfusion had the lowest Syn-1 and sTM, while patients with OH and shock had elevated levels. OH was associated with increased sTM by 0.97 ng/mL (95% CI 0.39-1.57, p = 0.001) and Syn-1 by 14.3 ng/mL (95% CI -1.5 to 30.2, p = 0.08). Furthermore, shock was associated with increased sTM by 0.64 (95% CI 0.02-1.30, p = 0.04) and with increased Syn-1 by 23.6 ng/mL (95% CI 6.2-41.1, p = 0.008). CONCLUSIONS: Arrival OH was associated with elevated sTM and Syn-1, indicating endothelial dysfunction. Treatments aiming to stabilize the endothelium may be beneficial for injured patients with evidence of hypoperfusion, regardless of vital signs.
BACKGROUND: Shock-induced endothelial dysfunction, evidenced by elevated soluble thrombomodulin (sTM) and syndecan-1 (Syn-1), is associated with poor outcomes after trauma. The association of endothelial dysfunction and overt shock has been demonstrated; it is unknown if hypoperfusion in the setting of normal vital signs (occult hypoperfusion [OH]) is associated with endothelial dysfunction. We hypothesized that sTM and Syn-1 would be elevated in patients with OH when compared to patients with normal perfusion. METHODS: A single-center study of patients requiring highest-level trauma activation (2012-2016) was performed. Trauma bay arrival plasma Syn-1 and sTM were measured by enzyme-linked immunosorbent assay. Shock was defined as systolic blood pressure (SBP) <90 mm Hg or heart rate (HR) ≥120 bpm. OH was defined as SBP ≥ 90, HR < 120, and base excess (BE) ≤-3. Normal perfusion was assigned to all others. Univariate and multivariable analyses were performed. RESULTS: Of 520 patients, 35% presented with OH and 26% with shock. Demographics were similar between groups. Patients with normal perfusion had the lowest Syn-1 and sTM, while patients with OH and shock had elevated levels. OH was associated with increased sTM by 0.97 ng/mL (95% CI 0.39-1.57, p = 0.001) and Syn-1 by 14.3 ng/mL (95% CI -1.5 to 30.2, p = 0.08). Furthermore, shock was associated with increased sTM by 0.64 (95% CI 0.02-1.30, p = 0.04) and with increased Syn-1 by 23.6 ng/mL (95% CI 6.2-41.1, p = 0.008). CONCLUSIONS: Arrival OH was associated with elevated sTM and Syn-1, indicating endothelial dysfunction. Treatments aiming to stabilize the endothelium may be beneficial for injured patients with evidence of hypoperfusion, regardless of vital signs.
Authors: David N Naumann; Jon Hazeldine; David J Davies; Jon Bishop; Mark J Midwinter; Antonio Belli; Paul Harrison; Janet M Lord Journal: Shock Date: 2018-04 Impact factor: 3.454
Authors: Sisse R Ostrowski; Hanne H Henriksen; Jakob Stensballe; Mikkel Gybel-Brask; Jessica C Cardenas; Lisa A Baer; Bryan A Cotton; John B Holcomb; Charles E Wade; Pär I Johansson Journal: J Trauma Acute Care Surg Date: 2017-02 Impact factor: 3.313
Authors: Eveline A J van Rein; Rogier van der Sluijs; R Marijn Houwert; Amy C Gunning; Rob A Lichtveld; Luke P H Leenen; Mark van Heijl Journal: Am J Emerg Med Date: 2018-02-01 Impact factor: 2.469
Authors: Shibani Pati; Daniel R Potter; Gyulnar Baimukanova; David H Farrel; John B Holcomb; Martin A Schreiber Journal: J Trauma Acute Care Surg Date: 2016-04 Impact factor: 3.313
Authors: Brian J Eastridge; Jose Salinas; John G McManus; Lorne Blackburn; Eileen M Bugler; William H Cooke; Victor A Convertino; Victor A Concertino; Charles E Wade; John B Holcomb Journal: J Trauma Date: 2007-08
Authors: Ernesto Lopez; Zhanglong Peng; Rosemary A Kozar; Yanna Cao; Tien C Ko; Charles E Wade; Jessica C Cardenas Journal: Shock Date: 2020-02 Impact factor: 3.454
Authors: Pär I Johansson; John Bro-Jeppesen; Jesper Kjaergaard; Michael Wanscher; Christian Hassager; Sisse R Ostrowski Journal: PLoS One Date: 2015-03-19 Impact factor: 3.240
Authors: Pär I Johansson; Hanne H Henriksen; Jakob Stensballe; Mikkel Gybel-Brask; Jessica C Cardenas; Lisa A Baer; Bryan A Cotton; John B Holcomb; Charles E Wade; Sisse R Ostrowski Journal: Ann Surg Date: 2017-03 Impact factor: 12.969